MRK vs PLTR: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Palantir Technologies Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
VS
Palantir Technologies Inc. · Technology
$189.67
+2.4% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
PLTR has more upside to fair value
(+2.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
PLTR |
| Current Price |
$147.17 |
$189.67 |
| Fair Value Estimate |
$141.07 |
$194.30 |
| Upside to Fair Value |
-4.1%
|
+2.4%
|
| Market Cap |
$363.5B |
$435.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
29.6x
|
139.9x
|
| Price / Sales |
5.5x
|
70.7x
|
| Price / FCF |
22.6x
|
135.3x
|
| Revenue Growth YoY |
+5.1%
|
+92.8%
|
| Gross Margin |
75.4%
|
84.8%
|
| Operating Margin |
16.7%
|
42.8%
|
| Return on Equity |
6.6%
|
37.5%
|
| Dividend Yield |
2.31% |
0% |
| FCF Yield |
4.42%
|
0.74%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Palantir Technologies Inc. is a software infrastructure company founded in 2003 and headquartered in Denver that builds and deploys Gotham for intelligence and defense workflows, Foundry as a central data operating system for enterprises, Apollo for software delivery across environments, and its Artificial Intelligence Platform (AIP) for unified access to open-source, self-hosted, and commercial …
Accumulation Zones
| Metric |
MRK |
PLTR |
| Zone Low |
$105.80 |
$145.73 |
| Zone High |
$119.91 |
$165.16 |
| In Buy Zone? |
No
|
No
|